Monoclonal Antibody Reduces Hospitalizations for Bronchiolitis by 50% in Infants Under Six Months
In a groundbreaking real-world study, researchers have demonstrated that a single dose of nirsevimab, a long-acting monoclonal antibody developed to ...
